相似文献
1
Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation.
Cancers (Basel). 2022 May 13;14(10):2418. doi: 10.3390/cancers14102418.
2
Thermoradiotherapy combined with p53 gene therapy of human salivary gland adenocarcinoma cell line.
Oncol Rep. 2003 Jan-Feb;10(1):71-4.
3
Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability.
Acta Pathol Jpn. 1990 Feb;40(2):79-84. doi: 10.1111/j.1440-1827.1990.tb01546.x.
4
Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
Oncol Rep. 2003 Mar-Apr;10(2):415-20.
5
Clinical thermoradiotherapy: the influence of some prognostic parameters on recurrence-free survival.
Neoplasma. 1997;44(1):19-24.
6
3D radiobiological evaluation of combined radiotherapy and hyperthermia treatments.
Int J Hyperthermia. 2017 Mar;33(2):160-169. doi: 10.1080/02656736.2016.1241431. Epub 2016 Nov 1.
7
Realistic biological approaches for improving thermoradiotherapy.
Int J Hyperthermia. 2016;32(1):14-22. doi: 10.3109/02656736.2015.1099169. Epub 2015 Nov 25.
8
Thermoradiotherapy for locally recurrent breast cancer with skin involvement.
Int J Hyperthermia. 2001 Jul-Aug;17(4):291-301. doi: 10.1080/02656730110049538.
9
Thermoradiotherapy planning: Integration in routine clinical practice.
Int J Hyperthermia. 2016;32(1):41-9. doi: 10.3109/02656736.2015.1110757. Epub 2015 Dec 15.
10
[Current status of hyperthermia for deep-seated tumors].
Gan To Kagaku Ryoho. 1989 Mar;16(3 Pt 1):289-96.
引用本文的文献
1
High-throughput 3D spheroid screens identify microRNA sensitizers for improved thermoradiotherapy in locally advanced cancers.
Mol Ther Nucleic Acids. 2025 Mar 5;36(2):102500. doi: 10.1016/j.omtn.2025.102500. eCollection 2025 Jun 10.
2
Design and Validation of Experimental Setup for Cell Spheroid Radiofrequency-Induced Heating.
Sensors (Basel). 2023 May 5;23(9):4514. doi: 10.3390/s23094514.
本文引用的文献
1
The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells.
Cancers (Basel). 2022 Apr 19;14(9):2050. doi: 10.3390/cancers14092050.
2
Accurate Three-Dimensional Thermal Dosimetry and Assessment of Physiologic Response Are Essential for Optimizing Thermoradiotherapy.
Cancers (Basel). 2022 Mar 27;14(7):1701. doi: 10.3390/cancers14071701.
3
A Novel Framework for the Optimization of Simultaneous ThermoBrachyTherapy.
Cancers (Basel). 2022 Mar 10;14(6):1425. doi: 10.3390/cancers14061425.
4
Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer.
Cancers (Basel). 2022 Mar 1;14(5):1271. doi: 10.3390/cancers14051271.
5
Present Practice of Radiative Deep Hyperthermia in Combination with Radiotherapy in Switzerland.
Cancers (Basel). 2022 Feb 24;14(5):1175. doi: 10.3390/cancers14051175.
6
Heterogeneous Heat Absorption Is Complementary to Radiotherapy.
Cancers (Basel). 2022 Feb 11;14(4):901. doi: 10.3390/cancers14040901.
7
Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas.
Cancers (Basel). 2022 Jan 29;14(3):705. doi: 10.3390/cancers14030705.
8
Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients.
Cancers (Basel). 2022 Jan 27;14(3):656. doi: 10.3390/cancers14030656.
9
Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment.
Cancers (Basel). 2022 Jan 26;14(3):625. doi: 10.3390/cancers14030625.
10
Intensity-Modulated Radiotherapy with Regional Hyperthermia for High-Risk Localized Prostate Carcinoma.
Cancers (Basel). 2022 Jan 13;14(2):400. doi: 10.3390/cancers14020400.
Zotero 插件